elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Durvalumab
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Durvalumab
RIS
0.001
(Research Intensity Score)
Papers
210
Top papers
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
2024 · 1069 citations
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
2024 · 412 citations
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
2022 · 1198 citations
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
2024 · 357 citations
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
2024 · 274 citations
Newest papers
Management of Pulmonary Large-Cell Neuroendocrine Carcinoma (LCNEC): An Updated Review
2026 · 4 citations
Gemcitabine-cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma: effectiveness outcomes and characterization of the tumor microenvironment
2026 · 3 citations
Emerging therapies and translational advances in small cell lung cancer: Overcoming resistance
2026 · 2 citations
Results from the safety lead-in for a phase 1b/2 study of ivosidenib plus durvalumab and gemcitabine/cisplatin as first-line therapy in patients with locally advanced, unresectable or metastatic cholangiocarcinoma with an IDH1 mutation.
2026 · 2 citations
Cost-Effectiveness of Perioperative Durvalumab With Neoadjuvant Gemcitabine/Cisplatin in Muscle-Invasive Bladder Cancer Treatment
2026 · 1 citations
A sample from the 100 top papers behind Durvalumab.
Create a free account to browse them all →
Durvalumab's history
Research intensity over time
Explore Durvalumab's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Durvalumab's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link